Preparing for unannounced EU regulatory inspections – are you ready?
This article was originally published in Clinica
Executive Summary
Unannounced visits from notified bodies are going to be part of life for medtech manufacturers in the EU. But do you know how you would cope if two inspectors walked through the door, expected your staff to host the visit and your testing equipment to be dedicated for their immediate use? Do you know what costs you would have to bear? Here, Gert Bos* and Francoise Schlemmer* of notified body association TEAM-NB explain why it is critical that manufacturers and subcontractors practice and validate protocols for hosting such visits
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.